40 related articles for article (PubMed ID: 15325666)
1. Assessing the malignancy of suspicious breast microcalcifications: the role of contrast enhanced mammography.
Depretto C; D'Ascoli E; Della Pepa G; Irmici G; De Berardinis C; Ballerini D; Bonanomi A; Ancona E; Ferranti C; Scaperrotta GP
Radiol Med; 2024 Jun; 129(6):855-863. PubMed ID: 38607514
[TBL] [Abstract][Full Text] [Related]
2. Added value of semi-quantitative breast-specific gamma imaging in the work-up of suspicious breast lesions compared to mammography, ultrasound and 3-T MRI.
Meissnitzer T; Seymer A; Keinrath P; Holzmannhofer J; Pirich C; Hergan K; Meissnitzer MW
Br J Radiol; 2015 Jul; 88(1051):20150147. PubMed ID: 25882690
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-thymine scintigraphy may be a promising method in the diagnosis of breast cancer.
Ribeiro MP; Souza SA; Lopes FP; Rosado-de-Castro PH; Fonseca LM; Gutfilen B
Clinics (Sao Paulo); 2013; 68(3):283-9. PubMed ID: 23644845
[TBL] [Abstract][Full Text] [Related]
4. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies.
Amiri-Kordestani L; Basseville A; Kurdziel K; Fojo AT; Bates SE
Drug Resist Updat; 2012; 15(1-2):50-61. PubMed ID: 22464282
[TBL] [Abstract][Full Text] [Related]
5. Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Bénard F; Turcotte E
Breast Cancer Res; 2005; 7(4):153-62. PubMed ID: 15987467
[TBL] [Abstract][Full Text] [Related]
6. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis.
Taillefer R
Semin Nucl Med; 1999 Jan; 29(1):16-40. PubMed ID: 9990681
[TBL] [Abstract][Full Text] [Related]
7. [99mTc-MIBI characterization of breast microcalcifications. Correlations with scintigraphic and histopathologic findings].
Vanoli C; Antronaco R; Giovanella L; Ceriani L; Sessa F; Fugazzola C
Radiol Med; 1999; 98(1-2):19-25. PubMed ID: 10566292
[TBL] [Abstract][Full Text] [Related]
8. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
9. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
10. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
11. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ
Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with 99mTc-MIBI scintimammography in patients with breast microcalcifications.
Fondrinier E; Muratet JP; Anglade E; Fauvet R; Berger V; Lorimier G; Jallet P
Breast; 2004 Aug; 13(4):316-20. PubMed ID: 15325666
[TBL] [Abstract][Full Text] [Related]
13. Dynamic imaging: scintimammography.
Salvatore M; Del Vecchio S
Eur J Radiol; 1998 May; 27 Suppl 2():S259-64. PubMed ID: 9652532
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
